|
Monday, March 22 — 8:00 AM — Salon 1 & Balconies
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - Hematopathology
Chaired By: Daniel Knowles and Paul Kurtin
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
VpreB3, a Pre-BCR Associated Protein, Is Expressed by a Subset of Mature, Germinal Center B Cells and a Biomarker of Burkitt Lymphoma
(1424)
SJ Rodig, JL Kutok, JC Paterson, W Zhang, MA Shipp, T Grogan, SA Pileri, S Montes-Moreno, NA Johnson, S Ben-Neriah, P Farinha, MA Piris, R Gascoyne, T Marafioti. - Brigham & Women's Hospital, Boston, MA; University of Oxford, Oxford, United Kingdom; Ventana Medical Systems, Tucson, AZ; Dana-Farber Cancer Institute, Boston, MA; University of Arizona, Tucson, AZ; Bologna University School of Medicine, Bologna, Italy; Spanish National Cancer Centre (CNIO), Madrid, Spain; British Columbia Cancer Agency, Vancouver, Canada
|  Add |
| 8:15 |
Identification of a microRNA Signature Useful in the Differential Diagnosis between Burkitt Lymphoma and DLBCL
(1396)
S Montes-Moreno, L di Lisio, N Martinez, G Gomez, H Rodriguez, SM Rodrigez-Pinilla, P Mckelvie, JL Rios, J Menarguez, JC Cigudosa, MA Piris. - CNIO, Madrid, Spain; HGUGM, Madrid, Spain.
| Add |
| 8:30 |
Simple karyotype and BCL-6 Expression Predict a Diagnosis of Burkitt Lymphoma and Better Survival in IG-MYC rearranged High-Grade B-cell Lymphomas
(1433)
AC Seegmiller, R Garcia, R Huang, A Maleki, N Karandikar, W Chen. - The University of Texas Southwestern Medical Center, Dallas, TX.
| Add |
| 8:45 |
The Expression of the ER Stress Sensor GRP78/Bip Is a Prognostic Factor in DLBCL Patients Involved in the Response to CHOP-R and to Bortezomib Containing Regimens
(1398)
A Mozos, G Roue, P Jares, A Lopez-Guillermo, D Colomer, E Campo, A Martinez. - Hospital Clinic, Barcelona, Spain.
| Add |
| 9:00 |
DNA Methylation and Polycomb Repression in Follicular Lymphoma
(1406)
C O'Riain, M Calaminici, A Clear, RM Braziel, RD Gascoyne, A Rosenwald, E Campo, EB Smeland, LM Rimsza, WC Chan, L Staudt, TA Lister, J Fitzgibbon. - Barts and the London School of Medicine, London, United Kingdom; Lymphoma/Leukemia Molecular Profiling Project, Bethesda.
| Add |
| 9:15 |
Promoter Hypermethylation of SASH1 Supports a Tumor Suppressor Role in Diffuse Large B-cell Lymphomas
(1476)
T Zhang, K Nie, R Shaknovich, DM Knowles, W Tam. - Weill Cornell Medical College, New York, NY.
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Immunoglobulin Light Chain Usage Is Not Random in B-Cell Non-Hodgkin Lymphomas
(1467)
LR Wolgast, Q Xie, F Sen, P Bhattacharyya, T Selvaggi, H Xu, D Xu, M Pathan, Q Hu, J Bang, X Xue, J Pizzolo, H Ratech. - Montefiore Medical Center, Bronx, NY; New York University Medical Center, New York, NY; Hackensack University Medical Center, Hackensack, NJ; Boston University Medical Center, Boston, NY; Creighton University Medical Center, Omaha, NE; Albert Einstein College of Medicine, Bronx, NY
| Add |
| 11:15 |
IRF4-Dependent Cell Proliferation Is a Potential Therapeutic Target in Peripheral T-Cell Lymphomas
(1322)
AL Feldman, RA Wilcox, J Porcher, A Dogan, SM Ansell. - Mayo Clinic, Rochester, MN.
| Add |
| 11:30 |
MicroRNA Profiling of Anaplastic Large Cell Lymphoma
(1410)
KP Patel, D Ma, BA Barkoh, H Yao, R Sargent, E Drakos, LJ Medeiros, R Luthra. - The University of Texas M.D. Anderson Cancer Center, Houston, TX.
| Add |
| 11:45 |
MKK4 and MKK7 Interact with NPM-ALK and Contribute to Tumor Cell Proliferation and Survival in NPM-ALK+ Anaplastic Large Cell Lymphoma
(1420)
G Rassidakis, P Georgoulis, V Atsaves, P Tsioli, E Drakos, LJ Medeiros, P Panayiotidis, E Patsouris. - National and Kapodistrian University of Athens, Athens, Greece; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
| Add |
|
|
